Stocks skid after Fed signals it will slow down its easing
According to preliminary data, the S&P 500 lost 2.96%, while the Nasdaq Composite lost 3.62% and the Dow Jones Industrial Average fell or 2.61%. The Dow and S&P saw their biggest one-day percentage de
Micron's Stock Tumbles as Its Outlook Disappoints
Micron Technology issued a revenue outlook that came in below analysts’ expectations, sending shares lower in extended trading Wednesday.
Why Everything Everywhere All at Once isn’t just a movie — it’s the market
John Petrides, Portfolio Manager at Tocqueville Asset Management, spoke with Quartz for the latest installment of our “Smart Investing” video series.
Wall Street falls sharply as Fed indicates fewer rate cuts in 2025 to fight inflation
Central bank lowers benchmark federal funds rate by a quarter of a percentage point to between 4.25% to 4.5%
NKE, PLTR, or UBER: Which Large-Cap Stock Is the Best Pick?
Investors often look for opportunities to invest in large-cap stocks as they are generally associated with companies having a proven track record and well-established business models. The large-cap st
Michael Saylor's MicroStrategy arbitrage seals suggest underlying market risks
Prime brokerage desks are preparing for credit shocks as leveraged trading expands within cryptocurrency financial networks.
These Sectors Led Wednesday's Fed-Fueled Stock Market Sell-Off
Rate-sensitive stocks plummeted on Wednesday after the Federal Reserve scaled back its forecast for future interest rate cuts and projected inflation would run hotter than previously expected next yea
Fed's Powell Shocks Markets After Interest Rate Cut: 'It's A New Phase'
In a year marked by three consecutive rate cuts totaling 100 basis points, Federal Reserve Chair Jerome Powell said the Fed is shifting gears to a more cautious stance heading into 2025 as interest ra
Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'
Jefferies initiated a "buy" rating on Rocket Pharmaceuticals, based on the biotech firm's experimental gene therapies.
Analyst unveils top tech stocks to buy for 2025
An investment firm's analysts compile a list of their top tech recommendations for the coming year.